| Management target | Revenue 25.0% FY27 |
|---|
| Revenue growth | 59.1% YoY in Q1 FY27 |
|---|---|
| Margins | EBITDA margins expanded to 34.3% due to product mix |
| Demand visibility | Strong momentum in CDMO and Pharma Intermediates |
| Management confidence | Confident in 25% full-year growth |
Growth
Q1 FY27 Revenue rose 59.1% YoY to ₹3,297 Mn; EBITDA surged 122.1% and PAT grew 70.4% YoY.
Outlook
Management guides for 25% revenue growth for the full year with stable margins.
Risks
Muted performance in commodity chemicals segment and lower other income impacting PAT margins were noted.
Last quarter's promises, checked
Delivered
- Guided 25% revenue growth for FY27 → delivered 59.1% in Q1 (= BEAT)
- Guided EBITDA margin maintenance → delivered 34.3% vs 34.5% FY26 (= BEAT)
- Guided H1 contribution ~40% of top line → Q1 revenue ₹3,297 Mn on track (= BEAT)
Partly delivered
- Guided pilot plant completion by Q2 FY27 → construction ongoing (= PARTIAL)
- Guided electrolyte additive phase 2 completion Q1 FY27 → spillover capex remains (= PARTIAL)
Missed
- Guided BFC recovery to offset commodity weakness → Specialty Chemicals fell 10.6% (= MISS)
Investor Presentation filed with BSE, NSE: ACUTAAS. Summary written with AI assistance from the document.
Acutaas Chemicals Ltd: key numbers
- Share price
- ₹3,272.50
- Market cap
- ₹26,792 Cr
- Revenue (annual)
- ₹1,339 Cr
- Net profit (annual)
- ₹356.3 Cr
- P/E (TTM)
- 69.4×Sector 50.4×
- Promoter holding
- 32.66%+0.00% QoQ
- FII holding
- 21.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Acutaas Chemicals Ltd
All →Acutaas Chemicals Management Change
Acutaas Chemicals Limited has announced the re-appointment of Ram Mohan Lokhande as Executive Director and Anita Bandyopadhyay as Non-Executive Independent Director for a 60-month term.
Acutaas Chemicals Acquisition Worth ₹0.01 Cr
Acutaas Chemicals will acquire 100% of Enchem Ami Organics Private Limited for Rs. 1 Lakh, making it a wholly owned subsidiary.
- Value
- ₹0.01 Cr
- Execution
- One month
Acutaas Chemicals Merger & Restructuring Worth ₹0.01 Cr
Acutaas Chemicals will acquire 100% equity stake in step-down subsidiary Enchem Ami Organics for Rs. 1 Lakh, making it a direct wholly-owned subsidiary.
- Value
- ₹0.01 Cr
- Execution
- within one month
Acutaas Chemicals Annual General Meeting
Acutaas Chemicals Limited conducted its 19th Annual General Meeting on September 24, 2026, where shareholders transacted various ordinary and special business items.
Acutaas Chemicals Patent
Acutaas Chemicals Limited has received a patent from the Indian Patent Office for a process to prepare 2,4-dimethylthiophenol. The company now holds 11 patents.
Acutaas Chemicals Capacity Expansion
Acutaas Chemicals Limited inaugurated a new state-of-the-art Pilot Plant at Unit 1 in Sachin, Surat. The facility supports R&D for high potency active pharmaceutical ingredients.
- pilot plant
- 1.0 plants